Radiation Oncology Oncologist
Resume:
CURRICULUM VITAE
Name: David Lloyd Sherr, M.D., M.Sc., F.A.C.R., F.A.C.R.O.
Home Address: *** **** **** ******
Apt. 6-H
New York, New York 10023
Home Telephone: 212-***-****
Cell Telephone: 646-***-****
E-Mail: ***********@***.***
SSN: ***-**-****
Medical Staff Appointments:
Radiation Oncologist March 2022- Present
Queens Hospital Center
Jamaica, NY
Chief of Radiation Oncology April 2017 -February 2022
The Brooklyn Hospital Center
Radiation Oncologist December 2013-February 2022
The Brooklyn Hospital Center
121 Dekalb Avenue
Brooklyn, NY 11201
Radiation Oncologist August 2010 – December 2013
Rosetta Radiology
1421 Third Avenue
New York, NY 10028
Attending Radiation Oncologist April 2001 – August 2010
Department of Radiation Oncology
New York Presbyterian Hospital
Weill Cornell Medical Center
525 East 68th Street
New York, N.Y. 10065
Attending Radiation Oncologist July 1986 – February 2001
Department of Radiation Oncology
North Shore University Hospital
Manhasset, New York 11030
Academic Appointments:
Assistant Professor of Clinical Radiology April 2001 – August 2010
Weill Medical College of Cornell University
New York, New York
Assistant Professor of Clinical Radiology July 1996 – March 2001
New York University School of Medicine
New York, New York
Assistant Professor of Radiology July 1989 – June 1996
Cornell University Medical College
New York, New York
Instructor July 1986 – June 1989
Department of Radiology
Cornell University Medical College
New York, New York
Visiting Fellow July 1983 – June 1986
Department of Radiation Oncology
Columbia University College of Physicians & Surgeons
New York, New York
Postdoctoral Training:
Chief Resident July 1985 – June 1986
Department of Radiation Oncology
Columbia-Presbyterian Medical Center
New York, New York
Resident July 1983 – June 1986
Department of Radiation Oncology
Columbia-Presbyterian Medical Center
New York, New York
Resident July 1982 – June 1983
Department of Internal Medicine
Brookdale Hospital Medical Center
Brooklyn, New York
Intern July 1981 – June 1982
Department of Internal Medicine
Brookdale Hospital Medical Center
Brooklyn, New York
Education
M.Sc. (Clinical Epidemiology and Health Services Research),
Cornell University Graduate School of Medical Sciences, New York, NY - 2014
M.D., Albert Einstein College of Medicine, Bronx, New York – 1981.
B.A., (Summa Cum Laude), Yeshiva University, New York, New York - 1977
A.A., (Summa Cum Laude) Yeshiva University, New York, New York - 1977
Medical Licensure:
New York State License #150638
Certification:
Diplomate, American Board of Radiology (Radiation Oncology), 1987 [Lifetime]
Diplomate, National Board of Medical Examiners, 1982
Professional Society Memberships:
American College of Radiology (ACR)
American Society of Clinical Oncology (ASCO)
American Society for Therapeutic Radiology and Oncology (ASTRO)
American College of Radiation Oncology (ACRO)
New York Roentgen Society
New York Academy of Medicine
Honor Society Membership:
Alpha Epsilon Delta (Pre-Medical Honor Society)
Psi Chi (Psychology Honor Society)
Scholarships:
New York State Regents Scholarship
Yeshiva University Scholarship for Academic Excellence
Organizational Appointments:
Radio-isotope Utilization and Radioactive Research
Committee of North Shore University Hospital
Subcommittee on Licensing (7/86-6/94)
Chairman, Radiation Oncology Quality Assurance
Committee of North Shore University Hospital (9/90-3/01)
Radiation Therapy Oncology Group (RTOG)
New Investigators Committee (7/87-6/92)
Cancer Control Committee (7/87-7/89)
CCOP Evaluation Committee (7/89—7/91 and 7/98-3/01)
Brain Tumor Committee (7/98-3/01)
Chemoprevention Committee (7/93-3/01)
Brain Tumor Steering Committee (7/00-3/01)
GI Committee (7/03-2/10)
Education Committee (7/10-Present)
Institutional Review Board, North Shore University Hospital (1/93-3/01)
New York Roentgen Society – Executive Committee (2001-2005), Chairman, Radiation Oncology Section (2004-2005)
New York State Radiological Society – Alternate Councilor to ACR (2003 and 2004), Councilor to ACR (2005 to 2009)
Education and Research Committee/Graduate Medical Education Committee, New York Hospital of Queens (10/01-8/10)
Digestive Diseases Operations Council – New York Weill Cornell Medical Center (1/02 – 12/04)
Oncology Operations Council – New York Weill Cornell Medical Center (1/03 – 8/10)
American Society of Clinical Oncology – Oncology Training Program Committee (9/05 – 8/08)
American College of Radiology – Continuing Medical Education Committee (7/06 – Present)
Michael’s Mission – Scientific Advisory Board (4/12 to 12/14)
American Society for Radiation Oncology (ASTRO):
CME/MOC Committee of the Educational Council (10/12 to present)
Clinical Affairs and Quality Committee (9/13 to 10/15)
Collaborative Clinical Trial Memberships:
Radiation Therapy Oncology Group (RTOG)
Cancer and Leukemia Group B (CALGB)
Children’s Cancer Group (CCG)
National Surgical Adjuvant Project for Breast and Bowel Cancer (NSABP)
Collaborative Ocular Melanoma Study (COMS)
Gynecologic Oncology Group (GOG)
Pharmaceutical Industry Sponsored Research
1. Allos 007: Phase II Trial of RSR 13 and Concurrent Cranial RT for Newly Diagnosed Glioblastoma Multiforme
2. Allos 009: Phase III Trial of RSR13 and Concurrent Cranial RT for Brain Metastases.
3. Sanofi-Aventis OX-08-001: Oxaliplatin combined with radiation therapy for pancreatic cancer (January 2008)
4. A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy (February 2008)
5. BRAD-301: Phase III Randomized Study of Neuradiab in Combination with External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme”
6. A Phase I/II Trial of Maximal Resection, Local Radiation Boost with Concomitant Temozolomide, Followed by External Radiation Therapy with Concomitant Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme
American College of Radiology Appointments
Alternate Councilor – 2003, 2004
Councilor – 2005, 2006
Commission on Radiation Oncology - 2005
Fellowship – May 2006
American College of Radiation Oncology
Fellowship -2018
Administrative Appointments
Director, Residency Program in Radiation Oncology
Weill-Cornell Medical Center / New York Hospital of Queens
(12/1/01 – 8/20/10)
Director, Division of Radiation Oncology Brooklyn Hospital Center (5/2016- 12/2021)
Laboratory Research Experience
Immunopathology Laboratory, Department of Pathology, Montefiore Medical
Center 7/76-8/76 (Dr. Eugene Emeson, Director)
Radiobiology Biology Laboratory, Department of Radiation Oncology, Columbia Presbyterian Medical Center 7/85-12/85 (Dr. Eric Hall, Director)
Invited Lecturer
March 5, 2003 Grand Rounds, East Orange VA Hospital
Endovascular Brachytherapy to Prevent CAD Restenosis
April 3, 2003 Spring Meeting, New York Roentgen Society
Role of Brachytherapy in the Treatment of Lung Cancer
Spring 2006 Anesthesiology Grand Rounds, NYPH/WCMC
Role of Radiation Therapy in Management of Cancer Pain
March 2, 2007 NY Scientific Symposium on Rectal Cancer
Evolving Role of RT in the Management of Rectal Cancer
August 24, 2007 Association of Physician Assistants in Oncology Meeting
New Developments in Radiation Oncology
Feb 12, 2013 Mt. Sinai Medical Center Melanoma Conference
The Role of Radiation Therapy in Melanoma
Journal Reviewer
International Journal of Radiation Oncology, Biology, and Physics
Cancer Investigations
American Journal of Clinical Oncology
Practical Radiation Oncology
BMC
Awards and Honors
Fellowship, American College of Radiation Oncology 2018
Fellowship, American College of Radiology 2006
Radiation Oncology Residency Program, NYPH-Cornell Best Teacher Award, Clinical 2005-2006 and 2006-2007
Who’s Who in America 2004, 2005, 2006
Who’s Who in Education 2004, 2005, 2006
Who’s Who in Science and Engineering 2004, 2005, 2006
Who’s Who in Medicine and Healthcare 2006, 2010
New York Super Doctors, 2008
Honorary Surgeon, New York Department Police, Appointed June 2010
America’s Top Radiologists, 2010
ARRO Educator of the Year, 2010
America’s Top Radiologists, 2012
Castle Connolly “Top Doctor” in Radiation Oncology, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023
U.S. News and World Report, Top Doctor, 2012/2013
Fellowship, New York Academy of Medicine 2013
Consulting Positions
Eviti, Inc. (July 2013-November 2013)
Bibliography:
1.Sherr, D.L., Fountain, K.S., Piro, J.D., Chondrosarcoma metastatic to the oral cavity. Oral Surgery Oral Medicine Oral Pathology. 59: 622-626, 1985
2.Sherr, D.L., Fountain, K.S., Kalb, R. Cutaneous metastases from chondrosarcoma. Journal of Dermatologic Surgery and Oncology. 12:146-149, 1986
3.Sherr, D.L., The prevalence and causes of colonic cancer. Journal of the American Medical Association. 255:2294, 1986
4.Neugut, AI, Sherr, D.L., Robinson, E., Murray, T., Niveus, J. Differences in histology between first and second lung cancer. Cancer Epidemiology, Biomarkers and Prevention. 1:155-159, 1992
5.Sherr, D.L., Cowden’s Disease. Consultant 34:1344, 1994.
6.Cha, S., Schultz, E., McHeffey-Atkinson, B., Sherr, D.L. Case report: lymphoma involving the patella. Skeletal Radiology 25: 783-785, 1996.
7. Finger, P.T., Berson, A., Sherr, D.L., Riley, R., Balkin, R., Bosworth, J.L.: Radiation therapy for subretinal neovascularization Ophthalmology. 103:878-889, 1996
8. Berson, A.M., Finger, P.T., Sherr, D.L., Emery, R., Alfieri, A., Bosworth, J.L. Radiotherapy for age related macular degeneration: Preliminary results of a potential new treatment. Int. J. Radiat. Oncol. Biol. Phys. 36: 861-***-****.
9. Corn, B.W., Donahue, B.R., Rosenstock, J.R., Hyslop, T., Brandon, A.H., Hegde, H. Cooper, J.S., Sherr, D.L., Fisher, S.A., Berson, A., Koprorowski, C.D., Ruffer, J.E., Curran, W.J., Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience. The Cancer Journal from Scientific American 3:52-56, 1997.
10.Sherr, D.L., Finger, and P.T.: Radiation for age related macular degeneration. Seminars in Ophthalmology 12:26-33, 1997.
11.Corn, B.W., Donahue, B.R., Rosenstock, J.G., Cooper, J.S., Xie, Y., Brandon, A.H., Hedge, H.H., Sherr, D.L., Fisher, S.A., Berson, A., Han, H., Wahab, M.A., Koprowski, C.D., Rufer, J.E., Curran, W.J., Palliation of AIDS – related primary lymphoma of the brain: observations from a multi-institutional database. Int. J. Radiol. Oncol. Phys. 38: 601-605, 1997.
12.Sherr, D.L. Therapeutic options for superficial basal cell carcinomas; the role of radiation therapy. Arch Dermatol. 134:752, 1998.
13.Sherr, D.L.: Advanced prostate cancer and postoperative radiotherapy (Letter to the Editor). JAMA 297: 950, 2007.
14.Stessin, A., Meyer, J., Sherr, D.L.: Pre-operative radiation is associated with improved survival in patients with resectable pancreatic cancer: analysis of data from the Surveillance, Epidemiology, and End Results (SEER) registry. Int. J. Radiol. Biol. Phys. 72(4):1128-1133, 2008.
15.Wernicke, A.G., Sherr, D.L., Pannullo, S., Schwartz, T.H., et al: The role of dose escalation with Intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study. Brachytherapy 8: 132-133, 2009
16.Meyer, J.E., Sherr, D.L.: When less is more, when less is less: local excision in early rectal cancer (Editorial). Gastrointest Cancer Research 3: 123-124, 2009
17.Finger, P.T., Chin, K.J., Duvall, G., et al: Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology 116(4): 790-796, 2009.
18. Lebwohl B, Ballas L, Cao Y, Chan G, Grossman R, Sherr D.L., Woodhouse S,
Neugut AI. Treatment interruption and discontinuation in radiotherapy for rectal cancer. Cancer Investigation 28: 289-294, 2010.
19. Meyer, J., Sherr, D.L., Schnoll-Sussman, F., Pochapin, M., Christos, P.: Increasing incidence of rectal cancer in patients younger than 40 years of age: an analysis of the SEER database. Cancer 116(18): 4354-4359, 2010.
20. Stessin, A., Sherr, D.L.: Demographic disparities in utilization of adjuvant therapy for gastric adenocarcinoma and their effect on survival outcomes: a SEER-based retrospective study. Cancer Epidemiology, Biomarkers, & Prevention 20: 223-233, 2011.
21. Wernicke AG, Sherr D.L., Schwartz TH, Pannullo SC, Stieg PE, Boockvar JA, Ivanidze J, Moliterno JA, Parashar B, Trichter S, Sabbas AM, Nori D.: Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection. J Cancer Res Ther. 2010 Jan-Mar; 6(1):65-74.
22. Bao F, Rennert H, Sherr DL, Yantiss, RK: Neoadjuvant therapy induces loss of MSH-6 expression in colorectal carcinoma. Am J Surg Pathol 34(12): 1798-1804, 2010.
23. Wernicke AG, Sherr DL, Schwartz TH, Pannullo SC, Stieg PE, Boockvar JA, Moliterno JA, Ivanidze J, Trichter S, Sabbas AM, Parashar B, Nori D.: The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study. Brachytherapy. 2010 Jan-Mar; 9(1):91-9
24. Sherr DL: Positioning During Radiotherapy for Breast Cancer (Letter to the Editor). JAMA 309(3):137, 2013.
25. Rajappa P, Margetis K, Wernicke G, Ginter P, Cope W, Sherr DL, Lavi E, Fine RL, Schwartz TH, Bruckner H, Pannullo: Stereotactic radiosurgery plays a critical role in enhancing long-term survival in a patient with pancreatic cancer metastatic to the brain. Anticancer Res. 2013 Sep;33(9):3899-903
.
26. Sherr DL: CT Image of Male Breast Cancer Showing Primary Tumor and Metastatic Involvement of Bilateral Axillary Lymph Nodes and Bone. Practical Radiation Oncology (In Press)
Abstracts and Presentations:
1.Neugut, A.I., Murray, T., Nieves, J., Sherr, D.L., Robinson, E. Differences in histology between lung cancer occurring as a first or second primary. American Journal of Epidemiology, 130:799, 1989 (Presented at 1989 meeting of Society for Epidemiology Research, Birmingham, Alabama).
2.Zanzi, T., DeMarco, L., Desai, M., Vinciguerra, V., Kroop, S., Sherr, D.L., Lesser, M., Sollazzo, R., Margouloff, D., Ga-67 SPECT of the chest in patients with lymphoma, Radiology 173(p): 455, 1989. (Presented at 1989 Meeting of RSNA, Chicago, Illinois).
3.Sherr, D.L., Zanzi, I., Bosworth, J., DeMarco, L., Vinciguerra, V., Margouloff, D., Evaluation of response of Hodgkin’s Disease to thoracic irradiation using Gallium (Ga-67) scintigraphy and computerized tomography (CT), Proceedings of ASCO 9:260, 1990.
4.Zanzi, DeMarco, L., Vinciguerra, V., Desai, M., Kroop, S., Mandel, F., Sherr, D.L., Sollazzo, R., Robeson, W., Lesser, M., Margouleff, D., Ga-67 SPECT of the chest in patients with lymphoma (Presented at 1990 meeting of the Society of Nuclear Medicine, Washington, D.C.)
5. Zanzi, I., DeMarco, L., Sollazo, Kroop, S., Cinciguerra, V., Lesser, M., Desai, M., Robeson, W., Sherr, D.L., Magrgouloff, D., Evaluation of Ga-67 scintigraphy of the chest in lymphoma patients, European Journal of Nuclear Medicine 16:569, 1990. (Poster presentation at the 5th Congress-World Federation of Nuclear Medicine and Biology, Aug, 26-31, 1990. Montreal, Canada).
6. DeBlasio, D.S., Sherr, D.L., Perry, D.J., Bosworth, J.L., Total skin electron beam irradiation for cutaneous epidemic Kaposi’s Sarcoma. (Presented at Fourth World Congress on Cancers of the Skin, New York, New York, April 18-20, 1991.
7. Rush, S., Gal, D., Lovecchio, J.L., Sherr, D.L., Bosworth, J., Mandel, F.,
Aprigliano, T. Quality of life after effective adjuvant therapy for cancer of the endometrium. (Presented at meeting of International Society of Gynecological Cancer, Cairns, Australia, October 1991).
8. Sherr, D.L., Finger, P.T., Riley, R., Berson, A., Mishra, S., Bosworth, J.L. Palladium-103 ophthalmic plaque brachytherapy versus 6 MV external beam radiotherapy for subfoveal neovascularization: comparative dosimetry and preliminary results. (Poster presentation at 43rd Annual Meeting of Radiation Research Society, San Jose, California, April 1995).
9. Berson, A.M., Finger, P.T., Pisch, J., Sherr, D.L., Bosworth, J.L. Radiotherapy for subretinal neovascularization (Presented at 27th Annual Meeting of the American Society for Therapeutic Radiology Oncology, Miami Beach, Florida, October 1995).
10. Finger, P.T., Berson, A., Sherr, D.L., Riley, R., Balkin, A., Bosworth, J., Radiation therapy for subretinal neovascularization. (Presented at American Academy of Ophthalmology Meeting, Atlanta, Georgia, November 1995).
11. Loscalzo, J., Lichtman, S.M., Sherr, D.L., Gal, D., Lovecchio, J. Tolerance of patients over 65 years to pelvic irradiation for endometrial carcinoma. Proceedings of ASCO 15: 289, 1996.
12. Sherr, D.L., Finger, P.T., Berson, A.M., Bosworth, J.L., External beam radiation for the treatment of subretinal neovascularization: Experience with 140 patients (Presented at the 28th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Los Angeles, California, October 1996).
13.Corn, B.W., Donahue, B.R., Rosenstock, J.R., Hyslop, T., Brandon, A.H., Hegde, H., Cooper, J.S., Sherr, D.L., Fisher, S.A., Berson, A., Koprowski, C.D., Ruffer, J.E., Curran, W.J.: Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience. (Poster presentation at Society of Neuro-Oncology meeting, Santa Fe, New Mexico, November 1996).
14.Sherr, D.L., Finger, P.T., Berson, A.M., Bosworth, J.L.: External beam radiation for the treatment of subretinal neovascularization: Experience with 140 patients (Presented at the Radiation Therapy for Macular Degeneration Symposium, New York, NY, March 1997).
15.Singh, R., Sherr, D.L.: Risk Factors for local infectious complications of GliaSite balloon brachytherapy for brain tumors: implications for clinical practice (Poster presentation at the American Brachytherapy Society meeting, San Francisco, CA, June 2005).
16.Mehta, R., Kuritzky, N., Sherr, D., Nori, D.: Rates of PSA decline for prostate cancer patients treated with varying dose escalations of external beam radiation therapy (Poster presentation at the ASTRO/ASCO Prostate Cancer meeting, San Francisco, CA, June 2006).
17.Boockvar, J.A., Kan, C.C., Nori, D., Agusto-Sacido, A., O’Rourke, D.M., Kapoor, G., Sherr, D.L.: The effect of statins on U87MG glioblastoma cells with varying levels of EGFR signaling (Presented at the Society of Neuro-Oncology meeting, Orlando, November 2006).
18.Stessin, A., Meyer, J., Sherr, D.L.: Pre-operative radiation is associated with improved survival in patients with resectable pancreatic cancer: analysis of data from the Surveillance, Epidemiology, and End Results (SEER) registry. (Poster presentation at the American Society for Therapeutic Radiology and Oncology meeting, Los Angeles, CA, October 2007).
19.Singh, R., Meyer, J., Christos, P., Sherr, D.L.: Predictive factors for a pathologic complete response in patients receiving preoperative chemoradiation for locally advanced rectal cancer (Poster presentation at the American Society for Therapeutic Radiology and Oncology meeting, Boston, MA September 2008)
20.Sherr, D.L., Poli, J., Wernicke, G.A.: Kinetics of prostate specific antigen decline following treatment of localized prostate cancer with external beam radiotherapy: the impact of dose escalation (Poster presentation at the American Society for Therapeutic Radiology and Oncology meeting, Boston, MA September 2008)
21. Meyer, J., Sherr, D.L., Schnoll-Sussman, F., Pochapin, M., Christos, P.: Increasing incidence of rectal cancer in patients younger than 40 years of age: an analysis of the SEER database. (Oral presentation at the International Society of Gastrointestinal Oncology Meeting, Arlington, VA September 2008 and poster presentation at ASCO/ASTRO GI Meeting, San Francisco, CA January 2009)
22.Stessin, A., Sherr, D.L. Demographic disparities in utilization of adjuvant therapy for gastric adenocarcinoma and their effect on survival outcomes: a SEER-based retrospective study (Poster presentation at ASCO/ASTRO GI Meeting, San Francisco, CA January 2009)
23. Sherr, D.L., Stessin, A. Changes in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma: A retrospective analysis of two national databases (Poster presentation at ASCO/ASTRO GI Meeting, San Francisco, CA January 2009)
24. Wernicke, A.G., Sherr, D.L., Pannullo, S., Schwartz, T.H., et al: The role of dose escalation with Intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study. (Poster presentation at the American Brachytherapy Society meeting, Montreal, Canada, August 2009.)
25. B. Parashar, A. G. Wernicke, J. Osborne, S. Monni, S. Rice, D. L. Sherr, S. Vallabhajosula, D. Nori, S. Goldsmith, K. S. C. Chao, (Oral presentation at ASTRO October 2010, San Diego). Early Prediction of Radiation (RT)/ Chemoradiation (CRT) Response Using a Novel Functional Imaging Method- [^18 F] fluorocholine PET
26. Meyer, J.E., Pirog, E.C., Yang, A., Monni, S., Chao, K., Sherr, D.L.: HPV-associated histologic subtype of anal carcinoma is not associated with improved outcome after chemoradiation. (Poster presentation at ASTRO October 2010, San Diego).
27. Rajappa, R., Margetis, K., Wernicke, A.G., Sherr, D.L., Lavi, E., Schwartz, T., Pannullo, S.C.: Stereotactic radiosurgery plays a critical role in enhancing long-term survival in a patient with pancreatic cancer metastatic to the brain. (Poster presentation at Society of Neuro-Oncology meeting, 2011.)
28. Sherr, DL, Lesser M, Rich T, Crane CH, Suh JH, Song DY, Erickson BA, et al: Do socio-demographic factors affect overall survival in patients with unresectable pancreatic cancer? Results of a secondary analysis of RTOG data. (Poster presentation at ASTRO September 2013, Atlanta).
29. Sherr DL, Lesser M, Winter, K, Regine WF, Mowat R, Hayes, JP, Kessell IL, Narayan S, Chen Y, Singh AK, Delouya G, Meyer JE, DiPetrillo TA, Yost KJ, Gaur R, Abrams RA, Crane CH. Is Marital/Partner Status Associated with Survival in Patients with Resectable Pancreatic Cancer Treated with Adjuvant Post-operative Multi-Modality Therapy? Results Of Secondary Analysis of RTOG 97-04. (Poster presentation at ASTRO September 2014, San Francisco)
Contact this candidate